Experiments were conducted on the substrate specificity of phenoloxidase in Mycobacterium leprae, by using various phenolic compounds. Comparative studies were carried out with the enzyme from mammalian and plant sources. The phenolase of M. leprae was found to be similar to the enzyme of plant origin in oxidizing a variety of substrates; it was different from the mammalian enzyme, which has a limited substrate specificity. The findings confirmed that phenoloxidase is a specific property of M. leprae and is not a result of adsorption of host-tissue enzymes. The method used in separation of bacilli from infected tissues was evaluated for its effect on the viability of the organisms. This was tested by using M. lepraemurium as a model. The preparative procedure was found to have no adverse effect on the ability of the organisms to multiply in the mouse foot-pad. Several inhibitors of phenoloxidase have been tested-both substrate analogues and compounds which bind copper in the enzyme. Substances binding copper were found to be more effective. Since phenolase has been found to be a characteristic metabolic activity in M. leprae, nontoxic inhibitors of the enzyme offer possibilities of developing a rational chemotherapy of leprosy.
Because no proven culture of Mycobacterium leprae is as yet available, little progress has been made in understanding the metabolic properties of this microorganism. Recent investigations using concentrates of bacilli directly separated from infected tissues showed that M. leprae actively oxidizes 3,4-dihydroxyphenylalanine (dopa) to pigmented products (6) . Further studies revealed that the organism oxidizes D-dopa at the same rate as L-dopa and also utilizes other phenolic compounds such as catechol, epinephrine, and norephinephrine (5, 7) . It was therefore of interest to study more extensively this aspect of metabolism of M. leprae and to compare it with phenolase of mammalian and plant origin. The enzyme is widely distributed in nature and has been variously described as phenolase, phenoloxidase, phenolase complex, and tyrosinase. (E.C. 1.10.3.1, o-Diphenol: oxygen oxidoreductase).
M. leprae employed in the present investigation was separated from infected tissues. It would be useful to verify if the organisms retain their viability through the preparative procedure. This was tested by using M. lepraemurium as a model. It has also not been cultivated in bacteriological media; viability of the bacilli can be directly ascertained by inoculating in susceptible animals.
Dopa or its analogues are available in tissues of the human body (e.g., skin and peripheral nerve) which are the preferred sites of multiplication of the leprosy bacilli. Since phenoloxidase appeared to bea characteristic property of M. leprae, a study of inhibitors of this activity is important in developing a rational chemotherapy of leprosy.
MATERIALS AND METHODS
M. leprae was obtained at autopsy from the spleen of a patient who had died of lepromatous leprosy. The method employed and the purity of the preparation obtained were described earlier (5, 6 Effect of the preparative procedure on viability of the bacillus. Concentrates of M. lepraemurium were prepared from infected mouse spleen and liver by the procedure used for separating M. leprae (6, 5) . A crude fraction (fraction I) before purification and the final fraction (fraction II) were employed in the study to see if the bacilli retained their viability through the preparative procedure. The purified fraction was free of visible tissue debris as ascertained by ZiehlNeelsen staining method. Viability of the bacilli was assayed by their ability to multiply in the mouse foot-pad. The differential centrifugation, or the solutions used in the process, did not significantly affect the viability of the organisms (Table 2 ). It may be tentatively concluded that the technique employed is suited to preparation of pure (tissue free) and viable leprosy bacilli.
Effect of substrate analogues and copper chelators on oxidation of dopa. The property of oxidizing dopa is common to M. leprae, melanoma, and plant phenolase; moreover, the enzyme of the bacillus was found to be similar in substrate specificity to mushroom tyrosinase. Because leprosy organisms are obtained from infected human tissues available only in limited amounts, the inhibitors were initially tested on mushroom tyrosinase and melanoma extract. The effect of the added compound was estimated by its ability 
